Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

F2g Biotech Gmbh

Clinical trials sponsored by F2g Biotech Gmbh, explained in plain language.

Not yet finished but already full! 1

Breakthrough oral drug could save lives from deadly fungal infections

Disease control Ongoing

This study compares a new oral medication called olorofim against the current standard intravenous treatment for invasive aspergillosis, a serious fungal infection that often affects people with weakened immune systems. The trial focuses on patients who cannot use standard antifu…

Phase: PHASE3 • Sponsor: F2G Biotech GmbH • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC